Recombinant tissue plasminogen activator (r-TPA) in fibrin dissolution due to postoperative endophthalmitis

Annals of the Academy of Medicine Singapore

Volumn 35, Issue 10, 2006, Pages 723-725

  Riaz, Yasmin ^a   Mehta, Jodhbir S ^a,b   Fernando, Arosho ^a   Ferguson, Veronica ^a  

^a WESTERN EYE HOSPITAL   (United Kingdom)

^b SINGAPORE NATIONAL EYE CENTRE   (Singapore)

Author keywords

Cataract surgery; Fibrinolysis; Infection

Indexed keywords

ALTEPLASE; AMIKACIN; ANTIBIOTIC AGENT; ATROPINE; CHLORAMPHENICOL; DEXAMETHASONE; PREDNISOLONE; STEROID; VANCOMYCIN;

AGED; ARTICLE; CASE REPORT; CATARACT EXTRACTION; CLINICAL FEATURE; ENDOPHTHALMITIS; FIBRIN CLOT; FIBRINOLYSIS; HUMAN; INTRAOCULAR PRESSURE; MALE; POSTOPERATIVE COMPLICATION;

EID: 33751585019     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Newton J, Miller D. Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol 2005;139:983-7.
2. Semmens JB, Li J, Morlet N, Ng J; teamEPSWA. Trends in cataract surgery and postoperative endophthalmitis in Western Australia (1980-1998): the Endophthalmitis Population Study of Western Australia. Clin Experiment Ophthalmol 2003;31:213-9.
3. Kamalarajah S, Silvestri G, Sharma N, Khan A, Foot B, Ling R, et al. Surveillance of endophthalmitis following cataract surgery in the UK. Eye 2004;18:580-7.
4. Wong TY, Chee SP. The epidemiology of acute endophthalmitis after cataract surgery in an Asian population. Ophthalmology 2004;111:699-705.
5. Mayer E, Cadman D, Ewings P, Twomey JM, Gray RH, Claridge KG, et al. A 10-year retrospective survey of cataract surgery and endophthalmitis in a single eye unit: injectable lenses lower the incidence of endophthalmitis. Br J Ophthalmol 2003;87:867-9.
6. Nagaki Y, Hayasaka S, Kadoi C, Matsumoto M, Yanagisawa S, Watanabe K, et al. Bacterial endophthalmitis after small-incision cataract surgery. effect of incision placement and intraocular lens type. J Cataract Refract Surg 2003;29:20-6.
7. Colleaux KM, Hamilton WK. Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery. Can J Ophthalmol 2000;35:373-8.
8. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol 1995;113:1479-96.
9. Mamalis N, Kearsley L, Brinton E. Postoperative endophthalmitis. Curr Opin Ophthalmol 2002;13:14-8.
10. Montan PG, Koranyi G, Setterquist HE, Stridh A, Philipson BT, Wiklund K. Endophthalmitis after cataract surgery: risk factors relating to technique and events of the operation and patient history: a retrospective case-control study. Ophthalmology 1998;105:2171-7.
11. Yamada M, Mochizuki H, Yamada K, Kawai M, Mashima Y. Aqueous humor levels of topically applied levofloxacin in human eyes. Curr Eye Res 2002;24:403-6.
12. Doft BM, Kelsey SF, Wisniewski SR. Retinal detachment in the endophthalmitis vitrectomy study. Arch Ophthalmol 2000;118:1661-5.
13. Wolner B, Liebmann JM, Sassani JW, Ritch R, Speaker M, Marmor M. Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology 1991;98:1053-60.
14. Chaudhry NA, Flynn HW Jr, Murray TG, Tabandeh H, Mello MO Jr, Miller D. Emerging ciprofloxacin-resistant Pseudomonas aeruginosa. Am J Ophthalmol 1999;128:509-10.
15. Isenberg SJ, Apt L, Yoshimori R, Khwarg S. Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol 1985;103:1340-2.
16. Lam DS, Tham CC, Leung AT, Fan DS. Managing postoperative pupillary membranes. J Cataract Refract Surg 1997;23:972-3.
17. Kim MH, Koo TH, Sah WJ, Chung SM. Treatment of total hyphema with relatively low-dose tissue plasminogen activator. Ophthalmic Surg Lasers 1998;29:762-6.
18. Ozveren F, Eltutar K. Therapeutic application of tissue plasminogen activator for fibrin reaction after cataract surgery. J Cataract Refract Surg 2004;30:1727-31.
19. Mehta JS, Adams GG. Recombinant tissue plasminogen activator following paediatric cataract surgery. Br J Ophthalmol 2000;84:983-6.
20. Smith MF, Doyle JW. Use of tissue plasminogen activator to revive blebs following intraocular surgery. Arch Ophthalmol 2001;119:809-12.
21. Zalta AH, Sweeney CP, Zalta AK, Kaufman AH. Intracameral tissue plasminogen activator use in a large series of eyes with valved glaucoma drainage implants. Arch Ophthalmol 2002;120:1487-93.
22. Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 2001;108:2249-57.
23. Kamei M, Estafanous M, Lewis H. Tissue plasminogen activator in the treatment of vitreoretinal diseases. Semin Ophthalmol 2000;15:44-50.